86 related articles for article (PubMed ID: 30145202)
21. Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer.
Yu L; Liang Y; Cao X; Wang X; Gao H; Lin SY; Schiff R; Wang XS; Li K
Oncogene; 2017 May; 36(20):2910-2918. PubMed ID: 27893709
[TBL] [Abstract][Full Text] [Related]
22. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
Lin Z; Reierstad S; Huang CC; Bulun SE
Cancer Res; 2007 May; 67(10):5017-24. PubMed ID: 17510434
[TBL] [Abstract][Full Text] [Related]
23. ASXL2 promotes proliferation of breast cancer cells by linking ERα to histone methylation.
Park UH; Kang MR; Kim EJ; Kwon YS; Hur W; Yoon SK; Song BJ; Park JH; Hwang JT; Jeong JC; Um SJ
Oncogene; 2016 Jul; 35(28):3742-52. PubMed ID: 26640146
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.
Deblois G; Hall JA; Perry MC; Laganière J; Ghahremani M; Park M; Hallett M; Giguère V
Cancer Res; 2009 Aug; 69(15):6149-57. PubMed ID: 19622763
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
Han L; Liu B; Jiang L; Liu J; Han S
Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
[TBL] [Abstract][Full Text] [Related]
26. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
27. Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα.
Bloomfield M; Louie MC
Sci Rep; 2019 Aug; 9(1):12135. PubMed ID: 31431634
[TBL] [Abstract][Full Text] [Related]
28. Spatiotemporal control of estrogen-responsive transcription in ERα-positive breast cancer cells.
Hsu PY; Hsu HK; Hsiao TH; Ye Z; Wang E; Profit AL; Jatoi I; Chen Y; Kirma NB; Jin VX; Sharp ZD; Huang TH
Oncogene; 2016 May; 35(18):2379-89. PubMed ID: 26300005
[TBL] [Abstract][Full Text] [Related]
29. Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets.
Gates LA; Gu G; Chen Y; Rohira AD; Lei JT; Hamilton RA; Yu Y; Lonard DM; Wang J; Wang SP; Edwards DG; Lavere PF; Shao J; Yi P; Jain A; Jung SY; Malovannaya A; Li S; Shao J; Roeder RG; Ellis MJ; Qin J; Fuqua SAW; O'Malley BW; Foulds CE
Oncogene; 2018 Aug; 37(33):4581-4598. PubMed ID: 29748621
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of estrogen receptor α-36 by breast cancer oncogene IKKε promotes growth of ER-negative breast cancer cells.
Li Q; Sun H; Zou J; Ge C; Yu K; Cao Y; Hong Q
Cell Physiol Biochem; 2013; 31(6):833-41. PubMed ID: 23816933
[TBL] [Abstract][Full Text] [Related]
31. BAP18 facilitates CTCF-mediated chromatin accessible to regulate enhancer activity in breast cancer.
Sun G; Wei Y; Zhou B; Wang M; Luan R; Bai Y; Li H; Wang S; Zheng D; Wang C; Wang S; Zeng K; Liu S; Lin L; He M; Zhang Q; Zhao Y
Cell Death Differ; 2023 May; 30(5):1260-1278. PubMed ID: 36828916
[TBL] [Abstract][Full Text] [Related]
32. Luminal lncRNAs Regulation by ERα-Controlled Enhancers in a Ligand-Independent Manner in Breast Cancer Cells.
Miano V; Ferrero G; Rosti V; Manitta E; Elhasnaoui J; Basile G; De Bortoli M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462945
[TBL] [Abstract][Full Text] [Related]
33. The first decade of estrogen receptor cistromics in breast cancer.
Flach KD; Zwart W
J Endocrinol; 2016 May; 229(2):R43-56. PubMed ID: 26906743
[TBL] [Abstract][Full Text] [Related]
34. The RUNX Transcriptional Coregulator, CBFβ, Suppresses Migration of ER
Pegg HJ; Harrison H; Rogerson C; Shore P
Mol Cancer Res; 2019 May; 17(5):1015-1023. PubMed ID: 30655324
[TBL] [Abstract][Full Text] [Related]
35. Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching.
Murakami S; Nagari A; Kraus WL
Genes Dev; 2017 Aug; 31(15):1535-1548. PubMed ID: 28887413
[TBL] [Abstract][Full Text] [Related]
36. Mechanistic analysis of enhancer sequences in the estrogen receptor transcriptional program.
Tabe-Bordbar S; Song YJ; Lunt BJ; Alavi Z; Prasanth KV; Sinha S
Commun Biol; 2024 Jun; 7(1):719. PubMed ID: 38862711
[TBL] [Abstract][Full Text] [Related]
37. BRCA1-associated R-loop affects transcription and differentiation in breast luminal epithelial cells.
Chiang HC; Zhang X; Li J; Zhao X; Chen J; Wang HT; Jatoi I; Brenner A; Hu Y; Li R
Nucleic Acids Res; 2019 Jun; 47(10):5086-5099. PubMed ID: 30982901
[TBL] [Abstract][Full Text] [Related]
38. Alternatively Constructed Estrogen Receptor Alpha-Driven Super-Enhancers Result in Similar Gene Expression in Breast and Endometrial Cell Lines.
Bojcsuk D; Nagy G; Bálint BL
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32120995
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions.
Joosten SEP; Gregoricchio S; Stelloo S; Yapıcı E; Huang CF; Yavuz K; Donaldson Collier M; Morova T; Altintaş UB; Kim Y; Canisius S; Moelans CB; van Diest PJ; Korkmaz G; Lack NA; Vermeulen M; Linn SC; Zwart W
Genome Res; 2024 May; 34(4):539-555. PubMed ID: 38719469
[TBL] [Abstract][Full Text] [Related]
40. Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer.
Bailey SD; Desai K; Kron KJ; Mazrooei P; Sinnott-Armstrong NA; Treloar AE; Dowar M; Thu KL; Cescon DW; Silvester J; Yang SY; Wu X; Pezo RC; Haibe-Kains B; Mak TW; Bedard PL; Pugh TJ; Sallari RC; Lupien M
Nat Genet; 2016 Oct; 48(10):1260-6. PubMed ID: 27571262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
